Total Funding
79
65
Total FundingPost-IPO Debt raised
Growth Score 79 in past quarter
-8 pts
Heat Score 65 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73024
Capstone Holding biotechnology company committed to developing a pipeline of novel peptides and other molecules.
Randolph Steer: President and Chief Operating Officer- Terry Winters: DirectorPast Role: Clinuvel Pharmaceuticals, Director
About the Company
Capstone Holding is a diversified platform of building products businesses focused on distribution, brand ownership, and acquisition, offering proprietary lines of stone veneer, hardscape materials, and modular masonry systems. Capstone’s strategy combines operational efficiency, disciplined capital deployment, and brand control to build a
scalable, high-margin platform.
